我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

基于网络药理学探究黄芪-川芎药对治疗缺血性脑卒中的作用机制(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2021年01期
页码:
88-97
栏目:
方药研究
出版日期:
2021-06-28

文章信息/Info

Title:
Pharmacological Mechanism of Hedysarum Multijugum Maxim.and Chuanxiong Rhizoma for Treatment of Cerebral Ischemic Stroke Based on Network Pharmacology
文章编号:
1000-2723(2021)01-0088-10
作者:
陈红阳1杨志华1 2贾壮壮1 2刘 震3郭利平1 4△
(1. 天津中医药大学,天津 301617;2. 天津中医药大学第一附属医院,天津 300381; 3. 包头市中心医院,内蒙古 包头,014040;4. 天津市中医药研究院附属医院,300120)
Author(s):
CHEN Hongyang1 YANG Zhihua12 JIA Zhuangzhuang12 LIU Zhen3 GUO Liping1 4
(1. Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; 2. First Teaching Hospital of Tianjin University of TCM,Tianjin 300381,China; 3. Baotou Central Hospital, Baotou 014040, China; 4. Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, China)
关键词:
网络药理学黄芪-川芎缺血性脑卒中
Keywords:
network pharmacology Hedysarum Multijugum Maxim.and Chuanxiong Rhizoma cerebral ischemic stroke
分类号:
R285
DOI:
10.19288/j.cnki.issn.1000-2723.2021.01.011
文献标识码:
A
摘要:
目的基于网络药理学研究益气活血药对黄芪-川芎治疗缺血性脑卒中的作用机制。方法 从TCMSP数据库筛选黄芪、川芎活性化合物及靶点,在Uniprot数据库转化为基因靶点,通过Cytoscape 3.8.0构建化合物-靶点网络。在OMIM、DisGeNET、TTD数据库及文献报道收集缺血性脑卒中的治疗靶点,构建疾病-靶点网络。将化合物-靶点网络与疾病-靶点网络结合,筛选黄芪-川芎药对治疗缺血性脑卒中潜在核心靶点。利用STRING平台,获得核心靶点PPI网络。将核心靶点进行GO功能富集分析及KEGG富集分析。结果 筛选出黄芪-川芎药对的活性化合物17个,潜在核心靶点18个,包括IL-1β、NOS3、CASP3、BDNF等,可通过调节PI3K/AKT信号通路、MAPK信号通路、TLR信号通路、NF-κB信号通路等多个途径,参与调节NO生物合成、细胞凋亡、炎症及免疫反应、血管生成及器官再生等机制,从而改善缺血性脑卒中病理损伤。结论 通过网络药理学揭示了益气活血药对黄芪-川芎"多组分、多靶点、多机制"治疗缺血性脑卒中的作用特点,为其深入研究提供了科学依据。
Abstract:
Objective To explore the mechanism of Hedysarum Multijugum Maxim.and Chuanxiong Rhizoma for ischemic stroke based on network pharmacology. Methods The active chemical components and targets of Hedysarum Multijugum Maxim. zand Chuanxiong Rhizoma were obtained from TCMSP database. Targets were converted to genes by Uniprot database. Components-targets network were established by Cytoscape 3.8.0. The targets of ischemic stroke were obtained from OMIM、 DisGeNET、 TTD database and literatures, which constituted disease-targets network. Components-targets network and disease-targets network were merged and the potential core targets were predicted. Potential core targets were entered into the STRING platform to obtain a protein-protein interaction(PPI) network. Finally, GO functional enrichment analysis and the KEGG enrichment analysis of potential core targets were calculated. Results There are 18 predicted core targets for 17 compounds and the core targets includined IL1B、 NOS3、 CASP3、 BDNF, which may via regulating PI3K/AKT signaling pathway, MAPK signaling pathway, TLR signaling pathway, NF-κB signaling pathway, etc, affected regulations of NO biosynthesis, apoptosis, inflammation and immune response, angiogenesis and organ regeneration, etc, so as to participate in a series of physiological and pathological processes of ischemic stroke. Conclusion Network pharmacology exhibited multi-component, multi-target, and multi-mechanism biological effects of Hedysarum Multijugum Maxim and Chuanxiong Rhizoma, which provides a scientific basis for further study.

参考文献/References

[1] LEE N T,SELAN C,CHIA J S J,et al. Characterization of a novel model of global forebrain ischaemia-reperfusion injury in mice and comparison with focal ischaemic and haemorrhagic stroke[J]. Sci Rep,2020,10(1):18170.
[2] KATAN M,LUFT A. Global burden of stroke[J]. Semin Neurol,2018,38(2):208-211.
[3] SHI K,ZOU M,JIA D M,et al. tPA Mobilizes immune cells that exacerbate hemorrhagic transformation in stroke[J]. Circ Res,2021,128(1):62-75.
[4] WANG Y,XIAO G,HE S,et al. Protection against acute cerebral ischemia/reperfusion injury by QiShenYiQi via neuroinflammatory network mobilization[J]. Biomed Pharmacother,2020,125:109945.
[5] 姜超,徐中菊,王婷. 益气活血法在急性缺血性脑卒中治疗的应用[J]. 中西医结合心脑血管病杂志,2017,15(18):2271-2273.
[6] 陈红阳,刘震,贾壮壮,等. 基于数据挖掘的名老中医治疗缺血性脑卒中用药规律分析[J]. 云南中医学院学报,2020,43(5):79-84.
[7] 解静,高杉,李琳,等. 网络药理学在中药领域中的研究进展与应用策略[J]. 中草药,2019,50(10):2257-2265.
[8] 倪远宁,季晖,王琳娜,等. 一氧化氮与神经血管单元的关联性及相关药物研究进展[J]. 药学进展,2015,39(1):5-12.
[9] GHASEMI M,MAYASI Y,HANNOUN A,et al. Nitric Oxide and mitochondrial function in neurological diseases[J]. Neuroscience,2018,376:48-71.
[10] FENG J,CHEN X,GUAN B,et al. Inhibition of peroxynitrite-induced mitophagy activation attenuates cerebral ischemia-reperfusion injury[J]. Mol Neurobiol,2018,55(8):6369-6386.
[11] NISHIGAKI C,NAKAYAMA M,MIYATA H. Cell physiological responses of RAW264 macrophage cells to a 50-Hz magnetic field[J]. Int J Radiat Biol,2020,96(12):1628-1632.
[12] 李岩,王凯华. 脑缺血再灌注损伤过氧化相关机制及中医药治疗[J]. 解放军医药杂志,2019,31(5):113-116.
[13] 王仁杰,张艳军,王星星,等. 利用知识发现工具Arrowsmith探讨龙血竭及其有效成分治疗缺血性脑卒中的潜在作用机制[J]. 中国实验方剂学杂志,2017,23(22):194-201.
[14] 仇志富,颜勇,吴晓光. PI3K/Akt信号转导通路与神经细胞凋亡研究进展[J]. 中风与神经疾病杂志,2015,32(10):952-953.
[15] GUO C,HAO L J,YANG Z H,et al. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice[J]. Exp Neurol,2016,280:13-23.
[16] 董晓红,王悦阳,贺紫薇,等. 中医药调控脑缺血MAPK信号通路的研究进展[J]. 中国医药导报,2019,16(4):47-50.
[17] SI W,WANG J,LI M,et al. Erythropoietin protects neurons from apoptosis via activating PI3K/AKT and inhibiting Erk1/2 signaling pathway[J]. 3 Biotech,2019,9(4):131.
[18] GAO X,LI H,DONG Z,et al. Relationship between Erk1/2 signal pathway and nerve cell apoptosis rats with ischemic stroke[J]. Cell Mol Biol,2019,65(7):127-131.
[19] UZDENSKY A B. Apoptosis regulation in the penumbra after ischemic stroke:expression of pro- and antiapoptotic proteins[J]. Apoptosis,2019,24(9-10):687-702.
[20] MING Y C,CHAO H C,CHU S M,et al. Heparin-binding epidermal growth factor-like growth factor(HB-EGF)protected intestinal ischemia-reperfusion injury through JNK and p38/MAPK-dependent pathway for anti-apoptosis[J]. Pediatr Neonatol,2019,60(3):332-336.
[21] LIU R,XU N G,YI W,et al. Electroacupuncture attenuates inflammation after ischemic stroke by inhibiting NF-κB-mediated activation of microglia[J]. Evid Based Complement Alternat Med,2020,2020:8163052.
[22] STEEN-LOUWS C,HARTGRING S A Y,POPOV-CELEKETIC J,et al. IL4-10 fusion protein:a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10[J]. Clin Exp Immunol,2019,195(1):1-9.
[23] LI W,SUWANWELA N C,PATUMRAJ S. Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF-κB,ICAM-1,MMP-9 and caspase-3 expression[J]. Mol Med Rep,2017,16(4):4710-4720.
[24] YANG C H,YEN T L,HSU C Y,et al. Multi-targeting andrographolide,a novel NF-κB inhibitor,as a potential therapeutic agent for stroke[J]. Int J Mol Sci,2017,18(8):1638.
[25] 王萍,张密霞,庄朋伟,等. 脑缺血再灌注损伤的炎症反应机制研究进展[J]. 天津中医药大学学报,2014,33(5):317-320.
[26] NALAMOLU K R,SMITH N J,CHELLUBOINA B,et al. Prevention of the severity of post-ischemic inflammation and brain damage by simultaneous knockdown of Toll-like receptors 2 and 4[J]. Neuroscience,2018,373:82-91.
[27] TAJALLI-NEZHAD S,KARIMIAN M,BEYER C,et al. The regulatory role of Toll-like receptors after ischemic stroke:neurosteroids as TLR modulators with the focus on TLR2/4[J]. Cell Mol Life Sci,2019,76(3):523-537.
[28] HAN Y W,LIU X J,ZHAO Y,et al. Role of Oleanolic acid in maintaining BBB integrity by targeting p38MAPK/VEGF/Src signaling pathway in rat model of subarachnoid hemorrhage[J]. Eur J Pharmacol,2018,839:12-20.
[29] SHEN Y,GU J,LIU Z,et al. Inhibition of HIF-1α reduced blood brain barrier damage by regulating MMP-2 and VEGF during acute cerebral ischemia[J]. Front Cell Neurosci,2018,12:288.
[30] RUAN L,WANG B,ZHUGE Q,et al. Coupling of neurogenesis and angiogenesis after ischemic stroke[J]. Brain Res,2015,1623:166-173.
[31] 张荻,徐鸣曙,张英杰,等. 脑缺血后周细胞及相关血管生成信号通路的研究进展[J]. 中国康复理论与实践,2019,25(5):534-539.
[32] 董育玮,陆伦根. 血管生成素/Tie系统在血管生成中的作用[J]. 诊断学理论与实践,2014,13(3):331-335.
[33] WANG L,ZHANG X,LIU X,et al. Overexpression of α5β1 integrin and angiopoietin-1 co-operatively promote blood-brain barrier integrity and angiogenesis following ischemic stroke[J]. Exp Neurol,2019,321:113042.
[34] TORO-URREGO N,VESGA-JIM?魪NEZ D J,HERRERA M I,et al. Neuroprotective role of hypothermia in hypoxic-ischemic brain injury:combined therapies using estrogen[J]. Curr Neuropharmacol,2019,17(9):874-890.
[35] DUCKLES S P,KRAUSE D N. Mechanisms of cerebrovascular protection:oestrogen,inflammation and mitochondria[J]. Acta Physiol,2011,203(1):149-154.

备注/Memo

备注/Memo:
收稿日期: 2021 - 01- 13 基金项目: 天津市科技计划项目(15ZXLCSY00020);内蒙古自治区自然基金项目(2020BS08012) 第一作者简介: 陈红阳(1990-),女,在读博士研究生,研究方向:中医药治疗心脑血管疾病研究。 △通信作者: 郭利平,E-mail:lpgtjn@163.com
更新日期/Last Update: 1900-01-01